Menu
GeneBe

17-39665958-C-T

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_003673.4(TCAP):​c.353C>T​(p.Ala118Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000175 in 1,612,990 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A118E) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00083 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00011 ( 1 hom. )

Consequence

TCAP
NM_003673.4 missense

Scores

7
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:4

Conservation

PhyloP100: 1.45
Variant links:
Genes affected
TCAP (HGNC:11610): (titin-cap) Sarcomere assembly is regulated by the muscle protein titin. Titin is a giant elastic protein with kinase activity that extends half the length of a sarcomere. It serves as a scaffold to which myofibrils and other muscle related proteins are attached. This gene encodes a protein found in striated and cardiac muscle that binds to the titin Z1-Z2 domains and is a substrate of titin kinase, interactions thought to be critical to sarcomere assembly. Mutations in this gene are associated with limb-girdle muscular dystrophy type 2G. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.014618248).
BP6
Variant 17-39665958-C-T is Benign according to our data. Variant chr17-39665958-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 202105.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=4, Likely_benign=4}.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000834 (127/152338) while in subpopulation AFR AF= 0.00289 (120/41578). AF 95% confidence interval is 0.00247. There are 1 homozygotes in gnomad4. There are 63 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TCAPNM_003673.4 linkuse as main transcriptc.353C>T p.Ala118Val missense_variant 2/2 ENST00000309889.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TCAPENST00000309889.3 linkuse as main transcriptc.353C>T p.Ala118Val missense_variant 2/21 NM_003673.4 P1
TCAPENST00000578283.1 linkuse as main transcriptc.281C>T p.Ala94Val missense_variant 3/35

Frequencies

GnomAD3 genomes
AF:
0.000828
AC:
126
AN:
152220
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00287
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.000956
GnomAD3 exomes
AF:
0.000232
AC:
58
AN:
249614
Hom.:
1
AF XY:
0.000236
AC XY:
32
AN XY:
135414
show subpopulations
Gnomad AFR exome
AF:
0.00280
Gnomad AMR exome
AF:
0.0000868
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000272
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000355
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000107
AC:
156
AN:
1460652
Hom.:
1
Cov.:
30
AF XY:
0.000100
AC XY:
73
AN XY:
726666
show subpopulations
Gnomad4 AFR exome
AF:
0.00257
Gnomad4 AMR exome
AF:
0.0000671
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000126
Gnomad4 SAS exome
AF:
0.0000232
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000423
Gnomad4 OTH exome
AF:
0.000215
GnomAD4 genome
AF:
0.000834
AC:
127
AN:
152338
Hom.:
1
Cov.:
33
AF XY:
0.000846
AC XY:
63
AN XY:
74488
show subpopulations
Gnomad4 AFR
AF:
0.00289
Gnomad4 AMR
AF:
0.000196
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.000946
Alfa
AF:
0.000345
Hom.:
0
Bravo
AF:
0.000816
ESP6500AA
AF:
0.00227
AC:
10
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000247
AC:
30

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitterclinical testingAthena DiagnosticsOct 25, 2017- -
Likely benign, criteria provided, single submitterclinical testingGeneDxFeb 02, 2021This variant is associated with the following publications: (PMID: 24037902, 25351510, 26220970) -
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Dec 26, 2017- -
Cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingCHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern OntarioNov 03, 2015- -
Hypertrophic cardiomyopathy 1 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingMolecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart InstituteDec 30, 2019- -
TCAP-related disorder Benign:1
Likely benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesOct 24, 2022This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsMay 21, 2018This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Primary familial hypertrophic cardiomyopathy;C4225408:Hypertrophic cardiomyopathy 25 Benign:1
Likely benign, criteria provided, single submitterclinical testingInvitaeJan 28, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.19
CADD
Uncertain
24
DANN
Benign
0.97
DEOGEN2
Uncertain
0.63
D;.
Eigen
Uncertain
0.37
Eigen_PC
Uncertain
0.41
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Benign
0.84
T;T
M_CAP
Uncertain
0.13
D
MetaRNN
Benign
0.015
T;T
MetaSVM
Uncertain
0.17
D
MutationAssessor
Benign
1.9
M;.
MutationTaster
Benign
0.99
D;D
PrimateAI
Benign
0.45
T
PROVEAN
Benign
-1.9
N;.
REVEL
Uncertain
0.40
Sift
Benign
0.067
T;.
Sift4G
Benign
0.19
T;T
Polyphen
1.0
D;.
Vest4
0.18
MVP
0.96
MPC
0.94
ClinPred
0.050
T
GERP RS
5.7
Varity_R
0.13
gMVP
0.22

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs143233087; hg19: chr17-37822211; API